Search

Search Constraints

You searched for: Author/Creator Gregory, Nancy

Search Results

2. An Open–Label, Randomized, Multi–Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin–2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma. (1st January 2021)

8. Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry. Issue 1 (19th December 2017)